Staphylococcus aureus, Antibiotic Resistance, and the Interaction with Human Neutrophils.
Viktoria Rungelrath, Frank R DeLeo
https://pubmed.ncbi.nlm.nih.gov/32460514/Actively Recruiting
Led by National Institute of Allergy and Infectious Diseases (NIAID) · Updated on 2026-10-13
200
Participants Needed
1
Research Sites
N/A
Total Duration
Researchers are studying how human phagocytic cells, such as polymorphonuclear leukocytes, interact with bacterial pathogens. These cells normally kill ingested bacteria using reactive oxygen species and antimicrobial peptides, but some bacteria have developed ways to evade these defenses and cause serious diseases. The study aims to understand the mechanisms pathogens use to avoid immune responses and how phagocytes react to different bacteria, which may shed light on disease and inflammatory conditions. The research involves analyzing pathogen-phagocyte interactions using advanced techniques like genomics, proteomics, fluorescence assays, video microscopy, and electron microscopy. Healthy adult volunteers provide blood samples from which phagocytic leukocytes are isolated for study. The study does not involve treatment but focuses on laboratory investigations of immune cell function and bacterial evasion strategies. Participants will provide venous blood samples and may allow storage of blood or tissue for future research. The study involves various laboratory tests including enzymatic assays, biochemistry, immunology, and cell biology analyses. Researchers will measure how bacteria evade immune responses and how phagocytes respond. Safety and health of volunteers are monitored through medical screenings. Participation duration and visit schedules vary based on study needs.
CONDITIONS
Molecular Basis of Human Phagocyte Interactions With Bacterial Pathogens
F
Frank R De Leo, Ph.D.
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
National Institute of Allergy and Infectious Diseases (NIAID)
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Varies by participant
Participants provide blood samples used to isolate immune cells for laboratory study of phagocyte and bacterial interactions.
Blood collection visits as needed
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Have more questions? Get in touch with our team for quick support
Viktoria Rungelrath, Frank R DeLeo
https://pubmed.ncbi.nlm.nih.gov/32460514/Scott D Kobayashi, Natalia Malachowa, Frank R DeLeo
https://pubmed.ncbi.nlm.nih.gov/29642066/National Institute of Allergy and Infectious Diseases (NIAID)
Lead Sponsor